<- Go Home
Avid Bioservices, Inc.
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California. As of February 5, 2025, Avid Bioservices, Inc. was taken private.
Market Cap
$798.9M
Volume
1.2M
Cash and Equivalents
$33.4M
EBITDA
-$7.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$11.6M
Profit Margin
7.68%
52 Week High
$12.51
52 Week Low
$5.90
Dividend
N/A
Price / Book Value
17.83
Price / Earnings
-5.22
Price / Tangible Book Value
17.83
Enterprise Value
$970.8M
Enterprise Value / EBITDA
-635.76
Operating Income
-$20.4M
Return on Equity
133.29%
Return on Assets
-3.27
Cash and Short Term Investments
$35.1M
Debt
$207.0M
Equity
$44.8M
Revenue
$150.4M
Unlevered FCF
$3.0M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium